Vicky B Gregg insider trades: Quest Diagnostics (DGX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vicky reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | DGX | ↓ Sell | 1,250 | $191.76 | $240K | Direct | Nov 28, 2025 (3d) |
| Feb 5, 2025 | DGX | ↓ Sell | 1,250 | $164.57 | $206K | Direct | Feb 7, 2025 (2d) |
| Mar 4, 2024 | ACHC | ↓ Sell | 2,500 | $85.56 | $214K | Direct | Mar 6, 2024 (2d) |
| Feb 23, 2024 | DGX | ↓ Sell | 2,500 | $126.64 | $317K | Direct | Feb 23, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DGX insiders
Open-market trades in the last 12 months
About Vicky B Gregg's insider trades
Vicky B Gregg is a director at Quest Diagnostics (DGX). Since Feb 23, 2024, Vicky has reported no open-market purchases and 4 sales worth $976K on SEC Form 4. In the last 12 months: 1 sale ($240K).
Their filings also include grants and awards (44 filings), other transactions (10 filings), shares returned to the company (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DGX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.